CardiAQ™ Valve Technologies Reports First-in-Human Percutaneous Transfemoral, Transseptal Implantation with Its Second Generation Transcatheter Bioprosthetic Mitral Heart Valve Nearly 50% of patients suffering from a diseased mitral heart valve with severe, symptomatic regurgitation are currently denied open-heart surgery because it is considered too risky; in the future, percutaneous Transcatheter Mitral Valve Implantation (TMVI) may offer Continue Reading